Form 8-K
8-K — SONO TEK CORP
Accession: 0001171520-26-000166
Filed: 2026-07-08
Period: 2026-07-08
CIK: 0000806172
SIC: 3559 (SPECIAL INDUSTRY MACHINERY, NEC)
Item: Results of Operations and Financial Condition
Item: Regulation FD Disclosure
Item: Financial Statements and Exhibits
Documents
8-K — eps12668.htm (Primary)
EX-99.1 — SONO-TEK CORPORATION REPORTS FIRST QUARTER FISCAL 2027 RESULTS (ex99-1.htm)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K
8-K (Primary)
Filename: eps12668.htm · Sequence: 1
false
0000806172
SONO TEK CORP
0000806172
2026-07-08
2026-07-08
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 8, 2026
Sono-Tek Corporation
(Exact name of registrant as specified in its charter)
Commission File Number: 001-40763
New York
14-1568099
(State of Incorporation)
(I.R.S. Employer ID No.)
2012 Route 9W, Milton, New York
12547
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including area code: (845) 795-2020
Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligations of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value per share
SOTK
NASDAQ
Indicate by check mark whether the registrant is an emerging growth company as defined
in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2
of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02: Results of Operations and Financial Condition.
Item 7.01: Regulation FD Disclosure
On July 8, 2026, Sono-Tek Corporation issued a press release regarding its financial results
for the quarter ended May 31, 2026 in the form attached as exhibit 99.1.
The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not
be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)
or otherwise subject to the liabilities under such section and shall not be deemed to be incorporated by reference into any filing of
the Company under the Securities Act of 1933, as amended, or the Exchange Act.
Item 9.01: Financial Statements and Exhibits.
(d) Exhibits
99.1 Press Release dated July 8, 2026.
104 Cover Page Interactive Data File (embedded
within the Inline XBRL document)
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SONO-TEK CORPORATION
By: /s/ Stephen J. Bagley
Stephen J. Bagley
Chief Financial Officer
July 8, 2026
EX-99.1 — SONO-TEK CORPORATION REPORTS FIRST QUARTER FISCAL 2027 RESULTS
EX-99.1
Filename: ex99-1.htm · Sequence: 2
Exhibit 99.1
Sono-Tek Corporation Reports First Quarter Fiscal 2027
Results
Revenue Increased 10%; Gross Margin Expanded to 57%;
Operating Income Increased 86%; Net Income Increased 67%
Anticipating Continued Revenue Growth
in 1H 2027 Driven by Strong Medical Sector and Higher Value Production Systems
MILTON, N.Y., July 8, 2026 – Sono-Tek Corporation (Nasdaq: SOTK),
a leading developer and manufacturer of precision ultrasonic coating systems, today reported financial results for the first quarter of
fiscal 2027, ended May 31, 2026.
First Quarter Fiscal 2027 Highlights
Net sales increased 10% to $5.66 million
Gross margin expanded to 57% from 52%
Gross profit increased 21% to $3.21 million
Operating income increased 86% to $897,000
Net income increased 53% to $741,000, or $0.05 per diluted share
Cash, cash equivalents, and marketable securities increased to $16.65 million
with no debt
Backlog increased to approximately $7.73 million
Steve Harshbarger, CEO & President of Sono-Tek,
stated:
"Fiscal 2027 is off to a strong start with double-digit revenue growth,
meaningful margin expansion, and improved profitability, reflecting disciplined execution across our operations and the continued success
of our strategy of focusing on higher-value production systems in advanced technology markets, particularly medical devices.
"Our medical business was the primary growth driver this quarter, with strong
demand for specialty stent coating systems and Drug-Eluting Balloon platforms across the U.S., Europe, and Asia. This exceptional mix
of business-including a higher concentration of medical systems, shipments of higher-value production platforms, and a greater proportion
of U.S. based sales with lower distributor commission expenses, was a significant contributor to our gross margin expansion. While we
are very pleased with these results, product mix, geographic mix, and shipment timing naturally fluctuate from quarter to quarter, and
we would not expect this level of gross margin to be representative of every future quarter. Our technology is increasingly being selected
for applications requiring highly controlled, repeatable thin-film coatings, positioning Sono-Tek to benefit as manufacturing precision
requirements continue to increase across multiple industries.
"Looking ahead, we remain focused on expanding our installed base
of production systems, supporting customers as they scale from development into commercial manufacturing, and investing in the engineering
and commercial capabilities that will drive our next phase of growth. The Company continues to project revenue growth during the first
half of fiscal 2027, supported by strong medical demand and continued shipments of higher-value production systems, and we maintain our
previously communicated expectation of flat to modest revenue growth for the full fiscal year. This full-year outlook primarily reflects
the timing of several large production platform orders. As these higher-value production systems become a larger portion of our business,
quarterly revenue may increasingly be influenced by shipment timing. Our strong balance sheet provides the flexibility to execute these
priorities while continuing to create long-term value for shareholders."
Dr. Christopher L. Coccio, Executive Chairman, added:
"Our first quarter results reinforce the long-term strength of Sono-Tek's
ultrasonic coating technology platform and validate the strategic direction that we have pursued for many years. As precision manufacturing
requirements continue to increase across advanced industries, we believe we are well positioned to expand our leadership through continued
innovation and differentiated application expertise.
"We have spent decades building differentiated technology, deep application
expertise, and lasting customer relationships that continue to position us for future success. We believe these enduring strengths, together
with disciplined investment and a strong financial foundation, position Sono-Tek to capitalize on attractive long-term growth opportunities
while creating lasting shareholder value."
First Quarter Fiscal 2027 Results
Net sales increased 10% to $5.66 million, driven by strong
Medical demand, partially offset by lower Alternative Energy shipments compared with the prior-year period.
Gross profit increased 21% to $3.21 million, with gross margin
expanding from 52% to 57% due to favorable product mix and higher-value system shipments.
Operating expenses increased 6% to $2.32 million due to continued
investment in sales, engineering, and business development initiatives.
Operating income increased 86% to $897,000.
Net income increased 53% to $741,000, or $0.05 per diluted
share.
First Quarter Fiscal 2027 Results – (compared
with the prior year period)
Three Months Ended May 31,
Change
2026
2025
$
%
Net Sales
$ 5,661,000
$ 5,133,000
528,000
10%
Gross Profit
3,214,000
2,665,000
549,000
21%
Gross Margin
57%
52%
Operating Income
$ 897,000
$ 483,000
414,000
86%
Operating Margin
16%
9%
Net Income
$ 741,000
$ 485,000
256,000
53%
Net Margin
13%
9%
Basic Earnings Per Share
$ 0.05
$ 0.03
Diluted Earnings Per Share
$ 0.05
$ 0.03
Weighted Average Shares -Basic
15,713,000
15,734,000
Weighted Average Shares - Diluted
15,737,000
15,749,000
First Quarter Fiscal 2027 Product and Market Highlights
Market Sales
Medical: $3.95 million vs. $809,000
Electronics/Microelectronics: $863,000 vs. $943,000
Alternative Energy/Clean: $319,000 vs. $3.25 million
Industrial: $530,000 vs. $119,000
Emerging R&D and Other: $3,000 vs. $14,000
Medical growth was driven by specialty stent coating systems
in the U.S. and Drug-Eluting Balloon platforms across the U.S., China, and Europe. Alternative Energy declined due to reduced electrolysis
demand and the absence of solar shipments. Industrial growth reflected system upgrades and R&D nano-coating applications.
Product Sales
Fluxing Systems: $92,000 vs. $152,000
In-Line Coating Systems: $2.16 million vs. $3.05 million
Multi-Axis Coating Systems: $2.08 million vs. $677,000
OEM Systems: $231,000 vs. $130,000
Spare Parts, Services and Other: $1.10 million vs. $1.12 million
Total Net Sales: $5.66 million vs. $5.13 million
Multi-Axis growth was driven by strong demand across multiple
end markets. In-Line declined due to reduced clean energy shipments, including the absence of prior-year solar system deliveries. OEM
Systems increased on semiconductor and fluxer OEM demand, while services remained stable.
Balance Sheet, Backlog and Outlook
Balance Sheet: Cash, cash equivalents, and marketable
securities totaled $16.65 million, compared with $14.81 million at the prior year end. The Company had no outstanding debt.
Backlog: Combined equipment and service-related backlog at May 31, 2026 was $7.73
million, compared to backlog of $7.48 million at May 31, 2025, an increase of $250,000, or 3%. Backlog was down $1.39 million compared
to the fiscal 2026 year-end level of $9.12 million.
Outlook: Sono-Tek anticipates continued revenue growth and
profitability in the first half of fiscal year 2027 compared to the first half of fiscal year 2026, driven by expanding demand in the
medical sector and continued adoption of high value production-scale coating systems across multiple end markets. Total fiscal year 2027
revenue is currently projected to be relatively flat to modestly higher compared to fiscal year 2026, as visibility beyond the first half
remains limited due to continued uncertainty in certain clean energy sectors and the timing of shipments for higher value production scale
platforms.
About Sono-Tek
Sono-Tek Corporation is a global leader in the design
and manufacture of ultrasonic coating systems that are shaping industries and driving innovation worldwide. Our ultrasonic coating systems
are used to apply thin films onto parts used in diverse industries including microelectronics, alternative energy, medical devices, advanced
industrial manufacturing, and research and development sectors worldwide. Sono-Tek's inroads into the clean energy sector have shown transformative
results in next-gen solar cells, fuel cells, green hydrogen generation, and carbon capture applications.
Our product line is rapidly evolving, transitioning
from R&D to high-volume production machines with significantly higher average selling prices, showcasing our market leadership and
adaptability. Our comprehensive suite of thin film coating solutions and application consulting services are expected to generate unparalleled
results for our clients and help some of the world's most promising companies achieve technological breakthroughs and bring them to the
market. We strategically deliver our products to customers through a network of direct sales personnel, carefully chosen independent distributors,
and experienced sales representatives, ensuring efficient market reach across diverse sectors around the globe.
Our solutions are environmentally friendly, efficient
and highly reliable, and enable dramatic reductions in overspray, savings in raw material, water and energy usage and provide improved
process repeatability, transfer efficiency, high uniformity and reduced emissions.
Our growth strategy is focused on leveraging
our innovative technologies, proprietary know-how, unique talent and experience, and global reach to further develop thin film coating
technologies that enable better outcomes for our customers’ products and processes. For further information, visit www.sono-tek.com
Safe Harbor Statement
This news release contains forward looking statements regarding
future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual
results to differ materially. These “forward-looking statements’ are based on currently available competitive, financial
and economic data and our operating plans. They are inherently uncertain, and investors must recognize that events could turn out to
be significantly different from our expectations and could cause actual results to differ materially. These factors include, among
other considerations, general economic and business conditions, including political, regulatory, tax, competitive and technological
developments affecting our operations or the demand for our products; inflationary and supply chain pressures; continued strength of
sales to the medical device and electronics markets; increased private and public funding for the clean energy sector; continued
strong demand for Sono-Tek’s suite of thin film coating solutions and application consulting services in the clean energy and
other markets; maintenance of order backlog; evolving tariff policies; timely development and market acceptance of new products and
continued customer validation of our coating technologies; adequacy of financing; capacity additions, the ability to enforce
patents; maintenance of operating leverage; consummation of order proposals; timing of large orders and completion on schedule and
on budget; successful transition from primarily selling ultrasonic nozzles and components to a more complex business providing
complete machine solutions and higher value subsystems; and realization of first half and annual revenues and profitability within
the forecasted ranges of guidance. We undertake no obligation to update any forward-looking statement.
For more information:
Sono-Tek Corp.
Stephen J. Bagley
Chief Financial Officer
Ph: (845) 795-2020
info@sono-tek.com
Investor Relations
Kirin Smith, President
PCG Advisory, Inc.
ksmith@pcgadvisory.com
- Financial Tables to follow –
SONO-TEK CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
May 31, 2026
February 28,
(Unaudited)
2026
ASSETS
Current Assets:
Cash and cash equivalents
$ 8,982,075
$ 7,339,403
Marketable securities
7,669,872
7,469,649
Accounts receivable (less allowance of $12,225, respectively)
1,264,932
3,350,953
Inventories
4,063,132
3,923,350
Prepaid expenses and other current assets
659,518
743,295
Total current assets
22,639,529
22,826,650
Land
250,000
250,000
Buildings, equipment, furnishings and leasehold improvements, net
2,138,226
2,173,443
Intangible assets, net
27,892
29,791
Deferred tax asset
809,182
1,141,611
TOTAL ASSETS
$ 25,864,829
$ 26,421,495
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable
$ 935,442
$ 1,038,885
Accrued expenses
2,088,229
2,227,401
Customer deposits
2,006,896
3,069,743
Income taxes payable
147,984
255,398
Total current liabilities
5,178,551
6,591,427
Deferred tax liability
75,238
55,909
Total liabilities
5,253,789
6,647,336
Commitments and Contingencies (Note 10)
—
—
Stockholders’ Equity
Common stock, $.01 par value; 25,000,000 shares authorized, 15,716,723 and 15,710,389 issued and outstanding as of May 31, 2026 and February 28, 2026
157,167
157,104
Additional paid-in capital
10,282,508
10,186,858
Accumulated earnings
10,171,365
9,430,197
Total stockholders’ equity
20,611,040
19,774,159
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
$ 25,864,829
$ 26,421,495
See notes to unaudited condensed consolidated financial statements.
SONO-TEK CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
Three Months Ended May 31,
2026
2025
Net Sales
$ 5,661,159
$ 5,132,773
Cost of Goods Sold
2,447,241
2,468,259
Gross Profit
3,213,918
2,664,514
Operating Expenses
Research and product development costs
616,982
668,470
Marketing and selling expenses
1,024,984
858,151
General and administrative costs
674,792
654,525
Total Operating Expenses
2,316,758
2,181,146
Operating Income
897,160
483,368
Interest and Dividend Income
114,624
142,098
Net unrealized (loss) on marketable securities
(26,271 )
(21,923 )
Income Before Income Taxes
985,513
603,543
Income Tax Expense
244,345
118,558
Net Income
$ 741,168
$ 484,985
Basic Earnings Per Share
$ 0.05
$ 0.03
Diluted Earnings Per Share
$ 0.05
$ 0.03
Weighted Average Shares - Basic
15,713,185
15,733,955
Weighted Average Shares - Diluted
15,737,276
15,748,556
See notes to unaudited condensed consolidated financial statements.
SONO-TEK CORPORATION
PRODUCT, MARKET, AND GEOGRAPHIC SALES
(Unaudited)
Product Sales:
Three Months Ended May 31,
Change
2026
% of total
2025
% of total
$
%
Fluxing Systems
$
92,000
2%
$
152,000
3%
(60,000
)
(39%)
In-Line Coating Systems
2,159,000
38%
3,054,000
59%
(895,000
)
(29%)
Multi-Axis Coating Systems
2,075,000
37%
677,000
13%
1,398,000
206%
OEM Systems
231,000
4%
130,000
3%
101,000
78%
Spare Parts, Services and Other
1,104,000
20%
1,120,000
22%
(16,000
)
1%
TOTAL
$
5,661,000
$
5,133,000
$
528,000
10%
Market Sales:
Three Months Ended May 31,
Change
2026
% of total
2025
% of total
$
%
Electronics/Microelectronics
$
863,000
15%
$
943,000
19%
(80,000
)
(8%)
Medical
3,946,000
70%
809,000
16%
3,137,000
388%
Alternative Energy/Clean
319,000
6%
3,248,000
63%
(2,929,000
)
(90%)
Emerging R&D and Other
3,000
0%
14,000
0%
(11,000
)
(79%)
Industrial
530,000
9%
119,000
2%
411,000
345%
TOTAL
$
5,661,000
$
5,133,000
$
528,000
10%
Geographic Sales:
Three Months Ended
May 31,
Change
2026
2025
$
%
U.S. & Canada
$
3,530,000
$
3,543,000
$
(13,000
)
0%
Asia Pacific (APAC)
738,000
597,000
141,000
24%
Europe, Middle East, Africa (EMEA)
930,000
897,000
33,000
4%
Latin America
463,000
96,000
367,000
382%
TOTAL
$
5,661,000
$
5,133,000
$
528,000
10%
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 7
v3.26.1
Cover
Jul. 08, 2026
Cover [Abstract]
Document Type
8-K
Amendment Flag
false
Document Period End Date
Jul. 08, 2026
Entity File Number
001-40763
Entity Registrant Name
SONO TEK CORP
Entity Central Index Key
0000806172
Entity Tax Identification Number
14-1568099
Entity Incorporation, State or Country Code
NY
Entity Address, Address Line One
2012 Route 9W
Entity Address, City or Town
Milton
Entity Address, State or Province
NY
Entity Address, Postal Zip Code
12547
City Area Code
(845)
Local Phone Number
795-2020
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
Common Stock, $0.01 par value per share
Trading Symbol
SOTK
Security Exchange Name
NASDAQ
Entity Emerging Growth Company
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration